Evidence map›Paper›PMID 38399684›Full record

ArticleMicroorganisms2024

The Preclinical Validation of 405 nm Light Parasiticidal Efficacy on

Pravin R Kaldhone, Nazli Azodi, Hannah L Markle, Neetu Dahiya, Caitlin Stewart, John Anderson, Scott MacGregor, Michelle Maclean, Hira L Nakhasi, Sreenivas Gannavaram and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Pravin R KaldhoneDivision of Blood Components and Devices, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Nazli AzodiDivision of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Hannah L MarkleDivision of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Neetu DahiyaDivision of Blood Components and Devices, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Caitlin StewartDepartment of Electronic and Electrical Engineering, University of Strathclyde, Glasgow G1 1XW, UK.
John AndersonDepartment of Electronic and Electrical Engineering, University of Strathclyde, Glasgow G1 1XW, UK.ORCID 0000-0003-4151-1619
Scott MacGregorDepartment of Electronic and Electrical Engineering, University of Strathclyde, Glasgow G1 1XW, UK.
Michelle MacleanDepartment of Electronic and Electrical Engineering, University of Strathclyde, Glasgow G1 1XW, UK.
Hira L NakhasiDivision of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0003-4941-1620
Sreenivas GannavaramDivision of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0002-6557-8220
Chintamani AtreyaDivision of Blood Components and Devices, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Center for Biologics Evaluation and Research · USUniversity of Strathclyde · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Violet-blue light of 405 nm in the visible spectrum at a dose of 270 J/cm

Indexed as

405 nm lightLeishmaniapathogen reductionplateletstransfusion safetytransfusion transmissible parasites

Identifiers

PMID38399684
PMCPMC10893240
OpenAlexW4391323743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.